Chronic ouabain treatment enhances cardiac myosin ATPase activity in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 801-806

  Padilha, Alessandra S ^a   Moreira, Cleci M ^c   Meira, Eduardo F ^a   Siman, Fabiana D M ^a   Stefanon, Ivanita ^a,b   Vassallo, Dalton V ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^c Laboratory of Clinical Analysis   (Brazil)

Author keywords

Arterial pressure; Cardiac myosin ATPase; Ouabain; Ventricular pressure

Indexed keywords

CARDIAC MYOSIN; MYOSIN ADENOSINE TRIPHOSPHATASE; OUABAIN;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG RESEARCH; ENZYME ACTIVITY; HEART HEMODYNAMICS; HEART RATE; HEART VENTRICLE PRESSURE; INOTROPISM; MALE; NONHUMAN; RAT;

ANIMALS; BLOOD PRESSURE; ENZYME ACTIVATION; HEART RATE; MALE; MYOCARDIUM; MYOSINS; OUABAIN; RATS; RATS, WISTAR;

EID: 44249099046     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04916.x     Document Type: Article

References (40)

1. Hamlyn JM, Blaustein MP, Bova S et al. Identification and characterization of an ouabain-like compound from human plasma. Proc. Natl Acad. Sci. USA 1991 88 : 6259 63.
2. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: Relationships among plasma and tissue ouabain and blood pressure. J. Hypertens. 1994 12 : 549 60.
3. Mathews WR, DuCharme DW, Hamlyn JM et al. Mass spectral characterization of an endogenous digitalis-like factor from human plasma. Hypertension 1991 17 : 930 5.
4. +-pump activity. Hypertension 1982 4 : 575 80.
5. Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased in brain sodium and ouabain are mediated via brain Ang II. Am. J. Physiol. 1996 271 : H275 80.
6. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994 135 : 794 7.
7. D'Urso G, Frascarelli S, Balzan S, Zucchi R, Montali U. Production of ouabain-like factor in normal and ischemic rat heart. J. Cardiovasc. Pharmacol. 2004 43 : 657 62.
8. Cattell M, Gold H. Influence of digitalis glycosides on force of contraction of mammalian cardiac muscle. J. Pharmacol. Exp. Ther. 1938 62 : 116 25.
9. 2+ stores and cell responsiveness. Am. J. Physiol. 1993 264 : C1367 87.
10. Vassallo DV, Songu-Mize E, Rossoni LV et al. Effects of ouabain on vascular reactivity. Braz. J. Med. Biol. Res. 1997 30 : 542 52.
11. Yuan CM, Manunta P, Hamlyn JM et al. Long-term ouabain administration produces hypertension in rats. Hypertension 1993 22 : 178 87.
12. Rossoni LV, Salaices M, Miguel M et al. Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am. J. Physiol. Heart Circ. Physiol. 2002 283 : H2110 18.
13. Rossoni LV, Xavier FE, Moreira CM et al. Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci. 2006 79 : 1537 45.
14. Marín J, Redondo J. Vascular sodium pump: Endothelial modulation and alterations in some pathological processes and aging. Pharmacol. Ther. 1999 84 : 249 71.
15. Rossoni LV, Cunha V, França A, Vassallo DV. The influence of nanomolar ouabain on vascular pressor responses in modulated by the endothelium. J. Cardiovasc. Pharmacol. 1999 34 : 887 92.
16. Rodríguez-Mañas L, Sanchez-Ferrer CF, Pareja A et al. Neurogenic component of ouabain-evoked contractions is modulated by endothelium. Hypertension 1994 23 : 10 17.
17. + regulation proteins. Basic Res. Cardiol. 2003 98 : 90 6.
18. 2+-exchanger and β-adrenergic sensitization in rat hearts. Biochem. Biophys. Res. Commun. 2004 318 : 219 26.
19. Klotz C, Aumont MC, Berson G, Leger JJ, Preteseille M, Swynghedauw B. Cardiac myosin: Preparation, ATPase in chronic heart hypertrophy. Recent Adv. Stud. Cardiac Struct. Metab. 1975 5 : 263 71.
20. Cappelli V, Bottinelli R, Poggesi C, Moggio R, Reggiani C. Shortening velocity and myosin and myofibrillar ATPase activity related to myosin isoenzyme composition during postnatal development in rat myocardium. Circ. Res. 1989 65 : 446 57.
21. 2+-stimulated ATPase activity. Anal. Biochem. 1986 157 : 375 80.
22. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976 72 : 218 54.
23. +) ATPase associated with essential hypertension. Nature 1982 300 : 650 2.
24. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, Hamylin JM. Elevated concentrations of ouabain in patients with congestive heart failure. Circulation 1992 86 : 20 425.
25. Huang BS, Leenen FH. Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 1999 34 : 107 12.
26. Zhang J, Leenen FH. AT receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am. J. Physiol. Heart Circ. Physiol. 2001 280 : H1318 23.
27. Di Filippo C, Filippelli A, Rinaldi B et al. Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J. Hypertens. 2003 21 : 747 53.
28. Blaustein MP, Juhaszova M, Golovina VA. The cellular mechanisms of action of cardiotonic steroids: A new hypothesis. Clin. Exp. Hypertens. 1998 20 : 691 703.
29. Blaustein MP. Sodium/calcium exchanger and the control of contractilly in cardiac muscle and vascular smooth muscle. J. Cardiovasc. Pharmacol. 1988 12 : S56 68.
30. +. Am. J. Physiol. 2000 258 : H445 51.
31. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, Lingrel JB. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H477 85.
32. Padilha AS, Rossoni LV, Xavier FE, Vassallo DV. Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 2004 44 : 372 80.
33. Barker LA, Rossoni LV, Vassallo DV. Acute pressor actions of ouabain do not enhance the actions of phenylephrine or norepinephrine in anesthetized rats. J. Cardiovasc. Pharmacol. 2001 37 : 339 48.
34. Tucci PJF, Spadaro J, Cicogna AC, Bregagnollo EA. Coronary perfusion pressure as a determinant of ventricular performance. Experientia 1980 36 : 974 5.
35. Vassallo DV, Vasquez EC, Mill JC, Cabral AM. Time-course effects of sinoartic denervation on contractile sate of the rat myocardium. Am. J. Physiol. 1991 261 : H639 43.
36. Barany K. ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 1967 50 : 197 216.
37. Barnes GE, Bishop VS, Horwitz LD, Kaspar RL. The maximum derivatives of left ventricular pressure and transverse internal diameter as indices of the inotropic state of the left ventricle in conscious dogs. J. Physiol. 1973 235 : 571 90.
38. Braunwald E. Assessment of cardiac function. In : Braunwald E (ed.). A Textbook of Cardiovascular Medicine, 4th edn. WB Saunders, Philadelphia. 1992 419 43.
39. Weisser-Thomas J, Piacentino V, Gaughan JP, Margulies K, Houser SR. Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc. Res. 2003 15 : 57 : 974 85.
40. +-ATPase and biological significance of their cardiac glycoside binding site. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006 290 : R524 8.